v3.26.1
Net Income per Share
3 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Net Income per Share

(9) Net Income per Share

Basic net income per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the period. In computing diluted net income per share, the sum of the weighted-average number of shares of common stock outstanding during the period is used and only when their effect is dilutive, the weighted-average number of potential shares of common stock are included. In June 2019, the Company sold 422,718 shares of common stock and pre-funded warrants to purchase an aggregate of 169,874 shares of common stock at an exercise price of $135 per share, with $134.85 of such exercise price paid at the closing of the offering (see Note 8, Stockholders' Equity, in the audited financial statements included in the 2025 Annual Report). The shares of common stock into which the warrants may be exercised are considered outstanding for the purposes of computing net loss per share.

Basic and diluted EPS for the three months ended March 31, 2026 and 2025 were calculated as follows (in thousands, except share and per share data):

 

 

Three Months Ended March 31,

 

 

 

2026

 

 

2025

 

Numerator:

 

 

 

 

 

 

Net income (loss)

 

$

681

 

 

$

317

 

Denominator:

 

 

 

 

 

 

Basic weighted-average common shares outstanding

 

 

12,394,912

 

 

 

12,283,543

 

Effect of dilutive securities

 

 

3,613

 

 

 

105,052

 

Diluted weighted-average common shares outstanding

 

 

12,398,525

 

 

 

12,388,595

 

 

 

 

 

 

 

 

Basic and Diluted EPS

 

$

0.05

 

 

$

0.03

 

The following potential shares of common stock, presented based on amounts outstanding at each period end, were excluded from the calculation of the diluted net loss per share attributable to common stockholders for the period indicated, because including them would have had an anti-dilutive effect.

 

 

 

As of March 31,

 

 

 

2026

 

 

2025

 

Purchase warrants

 

 

7,394,363

 

 

 

7,394,363

 

Outstanding options to purchase common stock

 

 

234,349

 

 

 

323,983

 

 

 

 

7,628,712

 

 

 

7,718,346